Heading background

Faruqi Law Blog

Latest on Facebook

Page 4 of 43

GMO False Advertising Claims On The Rise

January 5th, 2017

Genetically modified organisms (GMOs) appear today in many manufactured food products.  It is estimated that over 90% of the corn crops in the United States consist of GMO corn.  The U.S. Food and Drug Administration (FDA) has entertained public commentary on the term “natural,” but to date has not provided a definition.  As regarding products containing GMO, the FDA has not expressed...

Read full post

Information Privacy Concerns Will Continue To Plague Companies And Consumers in 2017

January 3rd, 2017

According to recent reports, consumers, in 2017, will continue to be threatened by data privacy attacks.  Data privacy is comprised of external cyber attacks; or violations of the Telephone Consumer Protection Act (TCPA) by the companies directly.  The victim is the consumer. In the past couple years, several widespread data breaches have plagued consumers of companies and organizations at...

Read full post

City of LA Calls Out Major Retailers For Deceiving Customers

December 30th, 2016

The City of Los Angeles has taken a stance against false and misleading sales practices by major retailers.  Recently, the city attorney slapped J.C. Penney, Sears, Kohl’s and Macy’s with false advertising lawsuits. The complaints, substantially similar in many respects, allege in sum and substance that the defendant retailer “creates an illusion of savings” as it “deliberately and...

Read full post

FDA Requests Public Input To Help Redefine ‘Healthy’ Claim On Our Food Labels?

December 2nd, 2016

The Federal Food and Drug Administration ("FDA") regulates food sold in the United States, including all processed foods such as cereals, snacks, and beverages.  The FDA oversees food content and food labeling. The health food industry has increased dramatically in the past 20 years with growing consumer demand for natural products.  The FDA regulates the term ‘healthy’ and its...

Read full post

The FTC Asks the Third Circuit to Take a Second Look at Product Hopping

November 30th, 2016

In June, we updated you on the first product hopping case to make its way to the Third Circuit.  In Doryx, generic manufacturer Mylan challenged Warner Chilcott’s scheme to stay one hop ahead of generic competition by changing its acne treatment first from a capsule to a tablet, then from one tablet strength to another, then from one tablet type to another.  With each change, generic...

Read full post

Page 4 of 43
Logo Twitter Facebook LinkedIn Google+